Beyond the Pages: CCJM Podcast

In this podcast featuring the Cleveland Clinic Journal of Medicine commentary, “Alpha-1 antitrypsin deficiency: A persistently underrecognized condition,” author James K. Stoller, MD, MS, Cleveland Clinic, joins moderator and Cleveland Clinic Journal of Medicine Editor-in-Chief Brian Mandell, MD, PhD. The podcast discusses the underrecognized nature of alpha-1 antitrypsin deficiency, causing harm, and reviews both established guideline-based and emerging AI-supported strategies to improve its detection.

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Artificial intelligence in medicine: How it works, how it fails,” authors Rick Rejeleene, PhD, and Neil B. Mehta, MBBS, MS, join moderator Adam Brown, MD, Cleveland Clinic. The trio discusses AI’s transformation of healthcare, with large language models emerging as important tools for clinical practice, education, and research.

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Artificial intelligence in medicine: How it works, how it fails,” authors Rick Rejeleene, PhD, and Neil B. Mehta, MBBS, MS, join moderator Adam Brown, MD, Cleveland Clinic. The trio discusses AI’s transformation of healthcare, with large language models emerging as important tools for clinical practice, education, and research.

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Complement inhibition: A whole new world,” lead author Dr. Nicholas Salupo, and senior author, Dr. Ali Mehdi, Cleveland Clinic, join moderator Dr. Narbeh Melikian, Cleveland Clinic London. The trio discusses the complement system, a central component of the innate immune system, and bridge to the adaptive immune system.

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Complement inhibition: A whole new world,” lead author Dr. Nicholas Salupo, and senior author, Dr. Ali Mehdi, Cleveland Clinic, join moderator Dr. Narbeh Melikian, Cleveland Clinic London. The trio discusses the complement system, a central component of the innate immune system, and bridge to the adaptive immune system.

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Update on antiobesity pharmacotherapy in adults: Current and emerging options,” Dr. Farah Ziyadeh, and Dr. Yael Mauer, Cleveland Clinic, join moderator Dr. Craig Nielsen, Cleveland Clinic. The trio discusses available antiobesity medications, including the incretin mimetics, and emerging antiobesity medications currently under investigation.

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Update on antiobesity pharmacotherapy in adults: Current and emerging options,” Dr. Farah Ziyadeh, and Dr. Yael Mauer, Cleveland Clinic, join moderator Dr. Craig Nielsen, Cleveland Clinic. The trio discusses available antiobesity medications, including the incretin mimetics, and emerging antiobesity medications currently under investigation.

Listen as Dr. Astefanos Al-Dalakta and Dr. Ashish Sarraju, Cleveland Clinic, join moderator Dr. George Thomas, Cleveland Clinic, to discuss what clinicians need to know about lipoprotein(a) in clinical practice. Topics discussed include summarizes evidence on risk, screening strategies, and evolving therapies for elevated lipoprotein(a).

This two-part podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Philip Zuccaro, BS, and Vasilis Vasiliou, PhD, both of the Yale School of Public Health, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Does my patient need testing for PFAS ‘forever chemicals’?”

This two-part podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Philip Zuccaro, BS, and Vasilis Vasiliou, PhD, both of the Yale School of Public Health, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Does my patient need testing for PFAS ‘forever chemicals’?”